戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                          Replication origins are 'licensed' for a single initiation event by loading
2 lent, inactivated influenza vaccine (TIV-HD) was licensed for adults aged >/=65 years.
3 forms, many viral vector-based vaccines have been licensed for animals.
4 of endotoxin priming, the NLRP3 inflammasome is licensed for ATP-induced release of processed IL-18,
5 tic vaccine from one manufacturer having now been licensed for commercial use and the expectation tha
6 d-generation tyrosine kinase inhibitors have been licensed for first-line use.
7 s vaccines, Rotarix (RV1) and RotaTeq (RV5), were licensed for global use in 2006.
8                                    OCVs have been licensed for >20 years, but their potential for pre
9                            New vaccines have been licensed for hepatitis A, varicella, and typhoid.
10 iruses for which no vaccines or therapeutics are licensed for human use.
11 e, only a few adjuvants and delivery systems are licensed for human use.
12 ree (abciximab, eptifibatide, and tirofiban) are licensed for human use.
13 ) have been shown to be efficacious and have been licensed for human use, the surface glycoproteins h
14 ine efficacy has been reported and none have been licensed for human use.
15           MF59-adjuvanted influenza vaccines were licensed for human vaccination, but the detailed me
16                               Zoster vaccine is licensed for persons aged 50 years or older, but its
17             PDE5 inhibitors (eg, sildenafil) are licensed for PH, but a role for PDE2 in lung physiol
18  children, and a live, oral vaccine may soon be licensed for prevention.
19                 Multiple biologic treatments are licensed for psoriasis.
20 in genome stability in eukaryotic cells, DNA is licensed for replication only after the cell has comp
21  the H. influenzae type b conjugate vaccines were licensed for routine immunization of infants.
22 te mitosis and early G1, replication origins are licensed for subsequent replication by loading heter
23 te mitosis and early G1, replication origins are licensed for subsequent use by loading complexes of
24 es widely used within PICUs neither of which being licensed for that use.
25 tazone, are insulin sensitizing agents, that are licensed for the management of hyperglycaemia.
26  fumarate (TDF) and adefovir dipivoxil (ADV) are licensed for the treatment of HIV-1 and HBV infectio
27 blockade with abatacept (CTLA4-Ig) will soon be licensed for the treatment of rheumatoid arthritis -
28                 Several novel therapies have been licensed for the treatment of myeloma in recent yea
29 diterpenoids include ingenol mebutate, which is licensed for the treatment of a precancerous skin con
30                                   Infliximab is licensed for the treatment of Crohn's disease (CD) an
31                                   Etanercept is licensed for the treatment of RA, including juvenile
32 e ligand of Toll-like receptor-7 (TLR7) that is licensed for the treatment of viral infections and ca
33 , including juvenile RA, and, more recently, was licensed for the treatment of psoriatic arthritis.
34 ts were newly licensed registered nurses who were licensed for the first time between August 1st, 200
35                                   Omalizumab is licensed for therapy in severe allergic asthma with a
36 ivated protein C (rhAPC [Xigris; Eli Lilly]) is licensed for treating human patients with severe seps
37 dditional analog, Pomalidomide, has recently been licensed for treatment of multiple myeloma, and is
38                              These analogues are licensed for type 2 diabetes, but their efficacy in
39         Two rotavirus vaccines have recently been licensed for use in >80 countries worldwide but not
40 clinical trial and a similar DNA vaccine has been licensed for use in horses.
41 o herpes simplex virus 2 (HSV-2) vaccine has been licensed for use in humans.
42                   A vaccine (4CMenB) has now been licensed for use in the European Union, comprising
43 on-based prognostic breast cancer tests have been licensed for use.
44 ce 1969, several rubella virus vaccines have been licensed for use; however, until the 1990s, use of
45 ials in lupus nephritis, no second line drug is licensed for use in induction of remission in lupus n
46 ive agent of Argentine hemorrhagic fever, it is licensed for use only in areas where Argentine hemorr
47 occal conjugated polysaccharide vaccine PC7V was licensed for use among children in 2000.
48 drivalent human papillomavirus (HPV) vaccine was licensed for use in 9- through 26-year-old females i
49 p A meningococcal conjugate vaccine (PsA-TT) was licensed for use in sub-Saharan Africa in 2009.
50 otype-specific disease before and after PCV7 was licensed for use.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。